Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Phase 2 Type 2 Diabetes (Oral + Subcutaneous) Published: November 2025 Participants: 448 adults with T2D on metformin SGLT2i Duration: Up to 36 weeks Results: - Once-weekly subcutaneous amycretin: up to 14.5% weight loss (vs
Months 23: Fat loss becomes increasingly noticeable, with measurable reductions in body circumference.Body composition may begin improving as muscle is maintained or gained while fat gradually decreases
Your treatment includes regular check-ins with your provider to monitor your progress, adjust your titration timeline, and optimize your results
This medication, often administered in units rather than milligrams, requires familiarity with its varying concentrations to ensure accurate dosing
US$ 20.67
US$ 29.69
US$ 23.31
US$ 29.86
US$ 26.49
US$ 20.14
US$ 28.13
